Literature DB >> 27240133

Same-day discharge after unilateral parathyroidectomy is safe.

John K Peel1, Adrienne L Melck1.   

Abstract

BACKGROUND: Minimally invasive parathyroidectomy (MIP) with intraoperative parathyroid hormone monitoring is the most common surgical approach among endocrine surgeons for primary hyperparathyroidism (PHPT). Overnight hospitalization after MIP represents a drain on resources and may be unnecessary. The aim of this study was to determine the safety of same-day discharge after MIP.
METHODS: We performed a retrospective cohort study of patients treated for PHPT between August 2010 and July 2015. Patients were stratified by their length of stay in hospital and compared in terms of postoperative complications.
RESULTS: During the study period 154 MIPs were performed. Of these, 101 patients were discharged on the day of their surgery (group 1) and the remaining 53 stayed 1 or more days (group 2). Three patients in group 2 required readmission within 30 days of discharge (p = 0.039). Seven patients in group 1 and 1 patient in group 2 visited the emergency department within 30 days of discharge (p = 0.72). Two patients in group 1 experienced persistent or recurrent PHPT (p = 0.55). Patients in group 2 were older than those in group 1 (69 v. 61 yr, p < 0.001) and had a higher mean American Society of Anesthesiologists classification of physical status (2.66 v. 2.24, p < 0.001).
CONCLUSION: Same-day discharge after MIP is a safe practice and saves the cost of an overnight stay in hospital. Same-day discharge should be considered for all patients undergoing MIP if there are no clear indications for overnight hospitalization.

Entities:  

Mesh:

Year:  2016        PMID: 27240133      PMCID: PMC4961486          DOI: 10.1503/cjs.013715

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  8 in total

1.  Six hundred fifty-six consecutive explorations for primary hyperparathyroidism.

Authors:  Robert Udelsman
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

2.  Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.

Authors:  H Chen; L J Sokoll; R Udelsman
Journal:  Surgery       Date:  1999-12       Impact factor: 3.982

3.  Minimally invasive parathyroidectomy for primary hyperparathyroidism: decreasing operative time and potential complications while improving cosmetic results.

Authors:  J Norman; H Chheda; C Farrell
Journal:  Am Surg       Date:  1998-05       Impact factor: 0.688

Review 4.  Surgical treatment of primary hyperparathyroidism.

Authors:  Mathew M Augustine; Paco E Bravo; Martha A Zeiger
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

Review 5.  Epidemiology, pathogenesis of primary hyperparathyroidism: Current data.

Authors:  Claudio Marcocci; Federica Saponaro
Journal:  Ann Endocrinol (Paris)       Date:  2015-04-25       Impact factor: 2.478

6.  Outpatient parathyroid surgery: ten-year experience: is it safe?

Authors:  Michael B Flynn; Mohiuddin Quayyum; Richard E Goldstein; Jeffery M Bumpous
Journal:  Am Surg       Date:  2015-05       Impact factor: 0.688

7.  Changing trends in thyroid and parathyroid surgery over the decade: is same-day discharge feasible in the United Kingdom?

Authors:  Parameswaran Rajeev; Rupesh Sutaria; Tarek Ezzat; Radu Mihai; Gregory P Sadler
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

8.  Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.

Authors:  Shelley Pallan; Aliya Khan
Journal:  Can Fam Physician       Date:  2011-02       Impact factor: 3.275

  8 in total
  2 in total

1.  Surgical management of MILD hyperparathyroidism.

Authors:  Adèle Lecourt; Gwenaëlle Creff; Paul Coudert; Olivier De Crouy Chanel; Pascal Guggenbuhl; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-30       Impact factor: 2.503

Review 2.  Role of Venous Sampling in the Diagnosis of Endocrine Disorders.

Authors:  Ryan W England; Eliza B Geer; Amy R Deipolyi
Journal:  J Clin Med       Date:  2018-05-14       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.